Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Overview
- Human gastrointestinal tract
- Diversity along GI tract
- Bacterial species distribution
- Role of microbiota in digestion
- Normal microbiota - development
- Normal microbiota - contributing factors
- Impact of disease
- Omics pipeline
- Omics technologies
- Fingerprinting of the gut microbiota
- Inflammatory bowel disease
- Crohn's disease (CD)
- CD - symptoms
- CD - complications
- Etiology of Crohn's Disease unknown
- CD - hypothothesis
- Evidence for microbial involvement in IBD
- Dysbiosis definition
- Genetics and IBD
- Value of twin studies
- Swedish twin cohort
- PCA of T-RFLP profiles (healthy)
- PCA of T-RFLP profiles (diseased)
- PCA of T-RFLP profiles (ileal differentiate)
- Similarity indices by two methods
- Value of biopsies
- Abundance of faecalibacterium in T-RFLP data
- Abundance of faecalibacterium by 3 methods
- Faecalibacterium prausnitzii: butyrate producer
- Abundance of E. coli in 454 data
- Potential microbial biomarkers of CD
- Omics pipeline - metaproteomics
- Genomics vs. proteomics
- Fecal metagenomes and metaproteomes
- Comparison of normalized metaproteomes
- Almost 30% of proteins were human
- Metaproteomics of twins with Crohn's disease
- Clustering of proteins according to disease
- Comparison of species composition
- Clusters of abundant proteins
- Omics pipeline - metametabolome
- Meta "metabolomics"
- Sample preparation method
- Clustering of metabolites according to disease
- Total masses
- Bile acid biosynthesis
- Summary of metabolite data
- Concluding remarks
- Acknowledgements
Topics Covered
- Human gastrointestinal tract
- The normal microbiota: development and contributing factors
- Impact of disease on the human intestinal microbiota and vice versa
- Fingerprinting of the gut microbiota
- Crohn's disease: symptoms, complications, etiology
- Evidence for microbial involvement in IBD
- Dysbiosis
- Genetics and IBD
- Twin studies
- Genomics vs. proteomics
- Metaproteomics and metagenomics
- Metabolite data
Talk Citation
Jansson, J. (2011, October 27). Microbiota and inflammatory bowel disease [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 27, 2024, from https://doi.org/10.69645/SYLW9905.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Janet Jansson has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.